(Q36048850)

English

Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Long-term visual outcomes of intravitreal ranibizumab treatment for wet age-related macular degeneration and effect on blindness rates in south-east Scotland (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

macular degeneration

1 reference

based on heuristic

inferred from title

author name string

S Borooah

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

V S Jeganathan

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

A-M Ambrecht

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

D Oladiwura

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

M Gavin

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

B Dhillon

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

P Cackett

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

publication date

5 June 2015

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

29

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1156-1161

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

https://scigraph.springernature.com/pub.10.1038/eye.2015.83

0 references

Baseline predictors for one-year visual outcomes with ranibizumab or bevacizumab for neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

2 October 2017

Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

2 October 2017

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

2 October 2017

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

2 October 2017

Unregistered visual impairment: is registration a failing system?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

2 October 2017

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

2 October 2017

BD8 certification of visually impaired people

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

2 October 2017

Unrecognised and unregistered visual impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

2 October 2017

Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

23 September 2018

Causes and prevalence of visual impairment among adults in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

23 September 2018

Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4565951

23 September 2018

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2015.83

21 January 2018

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap

1 reference

https://pubmed.ncbi.nlm.nih.gov/26043706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/26043706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimated cases of legal blindness and visual impairment avoided using ranibizumab for choroidal neovascularization: non-Hispanic white population in the United States with age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/26043706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modelling the prevalence of age-related macular degeneration (2010-2020) in the UK: expected impact of anti-vascular endothelial growth factor (VEGF) therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26043706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/26043706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/EYE.2015.83

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36048850&oldid=1991208802"